6-(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)hexanamide

Catalog No.: 
ACXREX557
CAS No.: 
141391-34-6
Molecular Formula: 
C14H16N2O3
Molecular Weight: 
260.29
6-(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)hexanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$109.00InquiryInquiry
100mg95%$155.00InquiryInquiry
250mg95%$214.00InquiryInquiry
1g95%$517.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)hexanamide
IUPAC Name6-(1,3-dioxoisoindolin-2-yl)hexanamide
MDL No.MFCD00266243
Molecular FormulaC14H16N2O3
Molecular Weight260.29
SMILESO=C(N)CCCCCN(C(C1=C2C=CC=C1)=O)C2=O
InChI KeyWBLOXKKSFGQLHP-UHFFFAOYSA-N
Synonym6-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)hexanamide;2H-Isoindole-2-hexanamide, 1,3-dihydro-1,3-dioxo-;6-(1,3-dioxoisoindolin-2-yl)hexanamide
CAS No.141391-34-6

Synthetic Route by SureRoute

1. ACXREX557 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXREX557 route product structure diagram
    ACXREX557141391-34-6
Inquiry

2. ACXREX557 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACNUDR270 route compound structure diagram
    ACNUDR2704443-26-9In Stock
  4. Then
  5. ACXREX557 route product structure diagram
    ACXREX557141391-34-6
Inquiry

3. ACXREX557 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACXREX557 route product structure diagram
    ACXREX557141391-34-6
Inquiry

Comments (0)